Liver Cancer Drug Fails to Live Up to Early Promise
Everolimus didn’t improve survival for people with advanced liver disease, study findsContinue Reading
Everolimus didn’t improve survival for people with advanced liver disease, study findsContinue Reading
Technique avoids ill effects related to long-term use of anti-rejection drugs, study says
Continue Reading
Everolimus didn’t improve survival for people with advanced liver disease, study findsContinue Reading
Technique avoids ill effects related to long-term use of anti-rejection drugs, study says
Continue Reading
Early study in mouse and human cells shows promise, but more research is neededContinue Reading
Review of two studies finds inconclusive evidence of successContinue Reading
Surgery won’t disrupt school schedule, kids can relax during recovery, doctor saysContinue Reading
ER study also finds high proportion without health insuranceContinue Reading
Poll finds support for stricter enforcement, harsher penaltiesContinue Reading
Irregular heartbeat that causes some attacks is often tough to detect, doctors sayContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.